<DOC>
	<DOC>NCT02044549</DOC>
	<brief_summary>to compare effectiveness and tolerability of carbetocin versus syntometrine in prevention of Postpartum hemorrhage after cesarean section</brief_summary>
	<brief_title>Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section</brief_title>
	<detailed_description>A double blind randomized study conducted on 450 pregnant subjected randomly either to single 100 Î¼g IV dose of carbetocin (150 women) or combination of 5 IU oxytocin and 0.2 mg ergometrine (300 women) after fetal extraction and before placental removal. Prevention of postpartum haemorrhage (PPH) after cesarean section (CS) had been evaluated by measurement of drop of Hemoglobin and hematocrit, incidence of PPH and number of subjects needed additional oxytocic</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<mesh_term>Syntometrine</mesh_term>
	<mesh_term>Ergonovine</mesh_term>
	<criteria>All participants are at 37 40 weeks of gestational age Noncomplicated pregnancy. Participants with placenta previa Patients with coagulopathy preeclamptic women known sensitivity to oxytocin or methergine were excluded</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Carbetocin</keyword>
	<keyword>syntometrine</keyword>
	<keyword>postpartum hemorrhage</keyword>
	<keyword>cesarean section</keyword>
</DOC>